Bioactive Compounds
-
BA2045 HalofuginoneSummary: Halofuginone (RU-19110), a derivative of Febrifugine, is a competitive inhibitor of prolyl-tRNA synthetase. - BA2044 TPE-MISummary: TPE-MI (Tetraphenylethenemaleimide) is intrinsically non-fluorescent before binding to thiols via maleimide.
-
BA2043 HydroxychloroquineSummary: Hydroxychloroquine (HCQ) is a synthetic oral antimalarial drug that is used in studies of malaria and autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. - BA2041 MethisazoneSummary: Methisazone (Marboran) is an antiviral agent that works by inhibiting mRNA and protein synthesis.
- BA2039 MitoxantroneSummary: Mitoxantrone is a potent topoisomerase II inhibitor.
- BA2038 CletoquineSummary: Cletoquine (Desethylhydroxychloroquine) is the main active metabolite of Hydroxychloroquine.
- BA2037 AmitivirSummary: Amitivir (LY217896) is a thiadiazole derivative with broad antiviral activity against orthomyxoviruses and paramyxoviruses.
- BA2036 GoitrinSummary: Goitrin ((S)-Goitrin), a product of the mustard oleosin-black mustard enzyme reaction, is a potent inhibitor of thyroid peroxidase.
- BA2035 PP7Summary: PP7 is an inhibitor of interactions.
- BA2034 TiloroneSummary: Tilorone is an orally effective antiviral agent and interferon inducer that also has potential antitumor, immunomodulatory, and metabolic modulatory effects.